Piramal Imaging enters into a strategic partnership with Ci-Co Healthcare

22 Nov 2013 Evaluate

Ci-Co Healthcare and Piramal Imaging SA, a division of Piramal Enterprises have entered into a strategic partnership and exclusive licensing agreement whereby Ci-Co Healthcare will obtain market authorization from the Korean Health Authorities and commercialize the PET amyloid imaging agent, florbetaben F18, in South Korea. Ci-Co Healthcare has assigned the manufacturing and supply of florbetaben F18 to DuChemBio, a market leading radiopharmacy network in Korea.

Piramal Enterprises is one of India’s largest diversified companies, with a presence in pharmaceutical, financial services and information management sectors.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 997.60
Shriram Finance 955.35
Aditya Birla Capital 346.80
Chola Invest & Fin. 1698.35
Tata Capital 337.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×